Delivery Order SPE2DB22D3011-SPE2DB24FQ0SC
- Not listed
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $9,555.22 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded solely to Amerisourcebergen Drug Corp, which...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $7,609.75 contract is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to Amerisourcebergen Drug Corp, which serves...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract valued at $102,235.72 to the Amerisourcebergen Drug Corp, Corporate Office division, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of the pharmaceutical product COSENTYX 300 MG DOSE-2 PENSML. This Delivery Order contract is placed under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999.00 through...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $3,961.99 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product, with a performance period through February 2, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC)...
- The Department of Defense's Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of a pharmaceutical product, COSENTYX UNOREADY 300 MG PEN 2ML. The $1,521.95 firm fixed-price contract has a completion date of May 8, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by AmerisourceBergen with DLA Troop Support Medical, which serves as the primary vehicle for...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $12,175.60 contract is for the supply of COSENTYX 300 mg doses in syringes. The delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued up to $999,999,999.00 through December 2025. This IDC serves as...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $12,486.91 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product, with a period of performance ending on March 13, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded by DLA to...
- The Defense Logistics Agency (DLA) awarded a $7,660.53 firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. This delivery order falls under a $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, which serves as the primary contract vehicle for the company to provide pharmaceutical products and medical supplies to DLA...
- The Defense Logistics Agency (DLA) awarded a $5,940.96 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide COSENTYX UNOREADY 300 MG PEN 2ML pharmaceutical products. The delivery order has a completion date of March 6, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp serves as a prime contractor for DLA Troop Support Medical, providing a wide range of pharmaceutical and medical supplies...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $24,296.40 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products, with a performance period through April 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded solely to AmerisourceBergen Drug...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB24FQ0SCDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a $6,087.80 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, which is a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML pharmaceutical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. Under this overarching IDC, Amerisourcebergen provides a wide range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications as well as critical care materials, to support the Department of Defense's medical treatment programs and facilities globally. The current $6,087.80 delivery order does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 4/18/24 |